Q4 2020
Released Mar 1, 2021, after the close
10-K filed Mar 1, 2021, 60 days after period end · 0001493152-21-005090
Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.33M$2.33M derived−26.2% vs Q4 2019+10.0% vs Q3 2020
Net Income-$759.00K-$759.00K derivedN/M vs Q4 2019N/M vs Q3 2020
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,302,000−31.5%
Operating Incomederived-$719,000N/M
Operating Cash Flowderived-$1,526,000N/M
Free Cash Flowderived-$1,526,000N/M
Margins · derived
Gross margin55.8%−4.3 pt vs Q4 2019
Operating margin-30.8%−21.6 pt vs Q4 2019
Net margin-32.5%−28.0 pt vs Q4 2019
What the release said
The release
Same quarter
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.33M | $3.16M | $1.61M | $1.30M |
| Net Income | -$759.00K | -$144.00K | -$725.00K | $1.29M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR